ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Poulton Jeffrey V. โ EVP, Chief Financial Officer
Shares
2,242
Price
$310.08
Total Value
$695,201.15
Nearby Earnings
Feb 12, 2026
EPS:0.82 (est: 1.16)-29.3%
Revenue:$1.10B (est: $1.15B)-4.5%
Transaction Details
| Insider | Poulton Jeffrey V. |
|---|---|
| Title | EVP, Chief Financial Officer |
| Transaction Date | Feb 13, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 18, 2026 |
| Document Date | Feb 12, 2026 |
| Shares Sold | 2,242 |
| Price per Share | $310.08 |
| Total Value | $695,201.15 |
| Shares Owned After | 59,802 |
| Derivative | No |
| Accession Number | 0001735276-26-000025 |
| Document | View SEC Filing |